Lannett Company develops, manufactures and distributes generic prescription pharmaceutical products in tablet, capsule and oral liquid forms to customers throughout the United States. 

TypePublic
HQPhiladelphia, US
Founded1942
Size (employees)1,251 (est)+12%
Websitelannett.com
Lannett Company was founded in 1942 and is headquartered in Philadelphia, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Lannett Company Office Locations

Lannett Company has offices in Philadelphia, Nashville, Wilmington, Washington and in 15 other locations
Philadelphia, (HQ)
13200 Townsend Road
Show all (19)
Report incorrect company information

Lannett Company Financials and Metrics

Lannett Company Revenue

Embed Graph
View revenue for all periods
Lannett Company's revenue was reported to be $684.56 m in FY, 2018
USD

Revenue (Q1, 2019)

155.1m

Gross profit (Q1, 2019)

67.4m

Gross profit margin (Q1, 2019), %

43.4%

Net income (Q1, 2019)

(287.5m)

EBIT (Q1, 2019)

(341.8m)

Market capitalization (4-Dec-2018)

213.9m

Closing stock price (4-Dec-2018)

5.5

Cash (30-Sep-2018)

150.3m

EV

890.5m
Lannett Company's current market capitalization is $213.9 m.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

273.8m406.8m566.1m637.3m684.6m

Revenue growth, %

49%33%

Cost of goods sold

99.3m100.5m237.4m300.0m363.7m

Gross profit

174.5m306.4m328.7m337.3m320.8m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Revenue

45.8m67.3m80.0m93.4m114.8m99.4m106.4m127.1m163.7m161.6m170.9m165.7m155.0m184.3m174.4m155.1m

Cost of goods sold

24.4m26.3m23.9m21.8m27.6m23.7m28.8m51.8m75.3m70.8m75.2m81.6m79.6m88.9m99.0m87.7m

Gross profit

21.4m41.0m56.1m71.6m87.2m75.6m77.6m75.3m88.4m90.7m95.8m84.2m75.4m95.4m75.4m67.4m

Gross profit Margin, %

47%61%70%77%76%76%73%59%54%56%56%51%49%52%43%43%
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

105.6m200.3m224.8m117.7m98.6m

Accounts Receivable

61.3m91.1m211.7m204.1m252.7m

Inventories

44.8m46.2m114.9m122.6m141.6m

Current Assets

265.5m370.5m612.8m523.7m526.9m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Cash

35.7m94.4m84.1m137.4m170.6m208.8m207.8m178.8m225.4m241.7m247.3m132.0m92.5m139.9m114.0m150.3m

Accounts Receivable

29.7m51.4m59.2m75.8m90.6m79.7m107.2m235.0m183.6m190.5m223.0m215.2m243.3m256.7m238.8m205.4m

Inventories

34.5m35.8m41.4m44.1m42.6m42.5m45.2m124.0m116.5m127.8m130.2m123.8m125.4m135.6m133.3m145.9m

Current Assets

122.4m204.4m237.1m287.8m334.0m367.2m400.4m607.0m601.6m646.0m665.6m554.7m508.0m568.3m521.8m524.4m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

57.2m150.0m44.9m(547.0k)28.7m

Depreciation and Amortization

6.0m5.6m33.4m55.3m55.1m

Inventories

(12.3m)1.4m15.3m(7.7m)(19.0m)

Accounts Payable

(1.7m)(2.5m)(3.7m)5.0m(5.0m)
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Net Income

(6.0m)10.6m33.6m35.0m79.8m116.0m33.2m46.7m41.3m(29.4m)(21.2m)(6.3m)13.3m27.3m40.0m(287.5m)

Depreciation and Amortization

1.6m3.2m4.8m1.3m2.6m4.0m1.9m8.1m20.1m14.3m28.0m41.6m13.8m27.4m40.6m14.8m

Inventories

(2.0m)(3.2m)(8.8m)774.0k2.2m2.4m960.0k6.0m13.3m(12.8m)(15.3m)(8.9m)(2.8m)(13.0m)(10.7m)(9.8m)

Accounts Payable

(6.0m)(3.4m)(1.4m)(7.0m)(1.9m)(4.0m)(1.9m)(4.9m)(5.4m)9.3m9.1m11.6m2.0m28.9m5.8m(7.3m)
USDY, 2018

EV/EBIT

-2.6 x

EV/CFO

16.3 x

Debt/Equity

2.7 x

Debt/Assets

0.7 x

Financial Leverage

4 x
Show all financial metrics
Report incorrect company information

Lannett Company News and Updates

Amneal Completes Transition Agreement With Lannett Company To Begin Commercialization Of Levothyroxine On December 1st

BRIDGEWATER, N.J., Nov. 12, 2018 /PRNewswire/ -- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) today announced that it has completed a transition agreement with Lannett Company. Under the terms of the agreement, Amneal will take over the distribution and marketing of Levothyroxine sodium...

LCI LOSS NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Lannett Company, Inc. - LCI

NEW YORK, Sept. 13, 2018 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Lannett Company, Inc. (NYSE: LCI) from February 7, 2018 through August 17, 2018, inclusive (the "Class...

Lifshitz & Miller LLP Announces Investigation of American Express Company, GDS Holdings Limited, Lannett Company, Inc., Mednax, Inc., Menlo Therapeutics Inc., Papa John's International, Inc., Tetraphase Pharmaceuticals, Inc. and Zion Oil & Gas, Inc.

NEW YORK, Sept. 12, 2018 /PRNewswire/ -- American Express Company (AXP) Lifshitz & Miller announces investigation into possible securities laws violations in connection with the FBI probing pricing practices within AXP's foreign-exchange unit. If you are an AXP investor, and would like...

Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Filed Against Lannett Company, Inc. - LCI

RADNOR, Pa., Sept. 6, 2018 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP alerts investors that a securities fraud class action lawsuit has been filed against Lannett Company, Inc. (NYSE: LCI) ("Lannett") on behalf of purchasers of Lannett securities between February...

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lannett Company, Inc. of Class Action Lawsuit and Upcoming Deadline - LCI

NEW YORK, Aug. 31, 2018 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Lannett Company, Inc. ("Lannett" or the "Company") (NYSE: LCI) and certain of its officers. The class action, filed in United States District Court, Eastern District of...
Report incorrect company information

Lannett Company Company Life and Culture

Report incorrect company information

Lannett Company Frequently Asked Questions

  • When was Lannett Company founded?

    Lannett Company was founded in 1942.

  • How many employees does Lannett Company have?

    Lannett Company has 1,251 employees.

  • What is Lannett Company revenue?

    Latest Lannett Company annual revenue is $684.6 m.

  • What is Lannett Company revenue per employee?

    Latest Lannett Company revenue per employee is $547.2 k.

  • Who are Lannett Company competitors?

    Competitors of Lannett Company include Kiniksa Pharmaceuticals, Sartorius Stedim BioOutsource and Neurosearch.

  • Where is Lannett Company headquarters?

    Lannett Company headquarters is located at 13200 Townsend Road , Philadelphia.

  • Where are Lannett Company offices?

    Lannett Company has offices in Philadelphia, Nashville, Wilmington, Washington and in 15 other locations.

  • How many offices does Lannett Company have?

    Lannett Company has 19 offices.